Table 3

Summary of assessment type, completers and timing

Assessment	Who to complete/action	Timeline (weeks post-randomisation)
Assessment	Who to complete/action	Screening	Baseline	Week 6	Week 12
Baseline data (collected from case notes)
Demographic data, eligibility, written informed consent	Research nurse	X
Background and medical history	Research nurse		X
Referral to local participating community palliative care team	Research nurse		X
Schedule initial appointment within 1 week; deliver usual care OR usual care and introduction of trial interventions as determined by randomisation allocation	Palliative care team		X
Clinical follow-up data (collected from case notes or hospice system for example, SystmOne)
Use of Intervention and usual care details	Palliative care team				X
All-cause mortality	Palliative care team				X
Serious adverse event reporting	Palliative care team		Ongoing reporting
Clinical follow-up data (collected from case notes, hospital system for example, SystmOne and PPM database)
Healthcare use	Research nurse				X
Pain medication	Research nurse			X	X
Date of referral to community palliative care, no and details of contacts	Research nurse				X
All-cause mortality	Research nurse				X
Serious adverse event reporting	Research nurse		Ongoing reporting
Patient-completed questionnaires (completed in clinic at baseline and at home/over telephone for follow-up visits)
BPI assessment	Trial researcher		X	X	X
7-point global rating change of pain	Trial researcher			X	X
Healthcare use (Health Economics questionnaire)	Trial researcher		X	X	X
Patient Pain Questionnaire40	Trial researcher		X	X	X
EQ-5D41	Trial researcher		X	X	X
EORTC QLQ-C3042	Trial researcher		X	X	X
Clinical follow-up data (collected via GP practice)
Date of referral to community palliative care	Trial researcher		Ongoing reporting
Survival status	Trial researcher/Leeds Institute of Clinical Trials Research		Ongoing reporting
Routine monitoring data
Uptake (patients and palliative care nurse) and patient-reported pain diaries	Trial researcher*		Ongoing reporting
Qualitative participant interviews	Trial researcher*		~6 or 12 weeks post-randomisation
Participant qualitative palliative care nurse end of trial interviews	Trial researcher*		End of trial

*Conducted through a different trial researcher involved in patient-completed questionnaire follow-up and clinical follow-up.
BPI, Brief Pain Inventory; EORTC, European Organization for Research and Treatment of Cancer; GP, general practitioner.